美国和日本富血小板血浆市场规模、份额和趋势分析报告：按类型、按应用、按最终用途、按国家、细分市场预测，2024-2030 年

美国和日本富血小板血浆市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计到2030年，美国和日本富血小板血浆市场规模将达到3.4845亿美元，2024年至2030年复合年增长率为10.15%。 。

美国和日本的富血小板血浆（PRP）市场受到整形外科疾病和运动伤害发病率增加、整容手术数量增加以及富血小板血浆医疗应用不断扩大的推动。此外，越来越多的关于使用富含血小板血浆的创伤治疗的实证研究进一步推动了整体市场的成长。

近年来，富含血小板的血浆产品在治疗肌肉骨骼疾病、整形外科疾病和运动伤害方面的应用越来越普及。多项研究发现，增加 PRP 中生长因子的浓度可能会加速癒合过程。 PRP 与干细胞和支架一起，是该领域本土产品的主要来源，并已被证明是癒合过程的真正先兆。美国疾病预防控制中心的资料显示，美国的体育运动参与度持续增加。美国约有3000万儿童和青少年参与运动，增加了年轻运动员运动伤害的风险。因此，整形外科疾病和运动伤害发病率的增加将对富血小板血浆治疗程序的需求产生正面影响。

整容手术的增加将推动对富含血小板的血浆产品的需求。例如，根据 ASPS 的数据，过去四年，PRP 在化妆品中的使用量增加了 25%。此外，美国和日本越来越多地采用整容手术，预计这将在研究期间为市场提供利润丰厚的机会。根据美国脸部整形与重组外科学会 (AAFPRS) 年度调查，注射剂是 2018 年脸部整形外科医师最常用的治疗选择。美国在整容手术和微创手术上的高额支出也推动了富含血小板的血浆市场。根据美容协会的资料，2022 年美国在微创和整容手术上的支出约为 118 亿美元，与前一年同期比较增长 2%。

富含血小板血浆的效用在美容和皮肤科中越来越受欢迎。儘管市售系统提供即用型无菌 PRP 悬浮液，但这些产品的高成本使医疗专业人员难以大规模部署 PRP套件。与其他治疗方法相比，PRP 注射的高成本是患者和临床医生的主要担忧。此外，由于缺乏支持 PRP 治疗的证据，保险不承保这些产品。美国整形外科医师学会指出，PRP 结果因患者而异，取决于患者的癒合能力。因此，与这些产品相关的成本可能会在预测期内阻碍市场。

美国和日本富血小板血浆市场报告亮点：

• 从类型来看，纯富血小板血浆细分市场占据主导地位，2023年收益占有率为51.24%，原因是纯富血小板血浆因其优势而采用率较高，并且在各个治疗领域的应用不断扩大。
• 从应用来看，预计杂项业务在预测期内将以最快的复合年增长率成长。
• 根据最终用途，医院细分市场在 2023 年占据市场最大收益占有率。用于美容目的的 PRP 治疗日益受到重视是推动该细分市场成长的关键因素。由于诊所数量的增加和医疗旅游业的增长，预计诊所部门在预测期内将以最快的复合年增长率增长。
• 美国市场的主导地位是由于监管支持以及许多专注于开发新的 PRP 製备系统的主要製造商在当地进行扩张等因素造成的。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章美国和日本富血小板血浆市场变数、趋势和范围

• 美国与日本富血小板血浆市场阵容展望
  • 母市场展望
  • 辅助设备市场
• 市场动态
  • 市场驱动因素分析
  • 市场抑制因素分析
• 美国和日本富血小板血浆市场分析工具
  • 波特五力分析
  • PESTLE分析
  • 主要观点观点分析
  • 市场机会分析
  • 买家认知调查
  • 主要观点观点分析

第 4 章美国和日本富血小板血浆市场 - 按类型細項分析，2018-2030 年

• 美国和日本富血小板血浆（Prp）市场：类型变异分析
  • 纯PRP
  • 多白血球RP
  • 其他的

第 5 章美国与日本富血小板血浆市场 – 按应用細項分析，2018-2030 年

• 美国和日本富血小板血浆（Prp）市场：应用变化分析
  • 整形外科
  • 其他的

第六章美国和日本富血小板血浆市场 - 按最终用途细分的細項分析，2018-2030 年

• 美国和日本富血小板血浆 (Prp) 市场：最终用途变化分析
  • 医院
  • 诊所
  • 其他的

第七章美国和日本的富血小板血浆（PRP）市场：国家估计和趋势分析

• 美国
  • 主要国家趋势
  • 美国富含血小板血浆
  • 竞争场景
  • 法律规范
  • 赎回场景
  • 日本

第八章竞争形势

• 公司分类
• Participants'Overview
• 财务绩效
• 产品基准评效
• 2023 年公司市场占有率分析
• 策略规划
  • 扩张
  • 合作
  • 新产品发布
  • 获得
  • 其他的
• List Of Emerging Companies
  • Johnson & Johnson Services, Inc.
  • Arthrex, Inc.
  • EmCyte Corporation
  • Dr. PRP USA LLC
  • Juventix Regenerative Medical, LLC
  • Terumo Corporation
  • Zimmer Biomet
  • Stryker
  • Apex Biologix
  • Celling Biosciences, Inc.
  • Factor Medical, Inc.
  • CAREstream America
  • Royal Biologics.

第9章 结论

U.S. And Japan Platelet Rich Plasma Market Growth & Trends:

The U.S. and Japan platelet rich plasma market size is anticipated to reach USD 348.45 million by 2030, registering a CAGR of 10.15% from 2024 to 2030, according to a new report by Grand View Research, Inc. The U.S. and Japan platelet rich plasma (PRP) market is driven by increasing incidence of orthopedic disorders and sports injuries, growing number of cosmetic surgeries, and expanding medical application of platelet rich plasma. Moreover, increasing evidence-based studies for platelet rich plasma-based wound healing are further propelling growth of overall the market.

The application of platelet rich plasma products in treatment of musculoskeletal conditions, orthopedic disorders, and sports injuries has become more prevalent over recent years. Several research studies have observed that an increased concentration of growth factors in PRP can potentially accelerate healing process. PRP has proven to be a major source of autologous products in the field and a true precursor for healing process along with stem cells & scaffold. According to U.S. CDC data, participation of individuals in sports in the U.S. is continuously rising. Around 30 million children and adolescents in the U.S. participate in sports, which increases risk of sports injuries among young athletes. Therefore, the rise in incidence of orthopedic disorders and sports injuries positively impacts demand for platelet rich plasma treatment procedures.

An increase in cosmetic surgeries drives demand for platelet rich plasma products. For instance, according to the ASPS, a 25% rise in use of PRP in cosmetics was observed in the past 4 years. Moreover, increasing adoption of cosmetic surgeries in the U.S. and Japan is expected to offer lucrative opportunities for the market during the study period. As per an annual survey of the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS), injectables became the most adopted treatment option by facial plastic surgeons in 2018. Large spending by Americans on cosmetic surgeries and minimally invasive procedures also drives platelet rich plasma market. According to the Aesthetic Society data, Americans spent approximately USD 11.8 billion on minimally invasive and cosmetic surgery procedures in 2022, reporting an increase of 2% over previous year.

The utility of platelet rich plasma is gaining popularity in aesthetics and dermatology. The commercially marketed systems provide ready-to-apply sterile PRP suspensions; however, high cost associated with these products makes it difficult for healthcare professionals to deploy PRP kits on a large scale. The higher cost of PRP injection as compared to other treatments is a major concern for patients and clinicians. Moreover, insurance policies do not cover these products due to a lack of supportive evidence for PRP therapies. The American Academy of Orthopedic Surgeons stated that PRP results differ from patient to patient, depending on healing capabilities. Thus, cost associated with these products is likely to impede the market over the forecast period.

U.S. And Japan Platelet Rich Plasma Market Report Highlights:

• Based on type, the pure platelet rich plasma segment dominated the market with a revenue share of 51.24% in 2023 owing to high adoption of pure platelet rich plasma because of its advantages and expanding applications across various therapeutic areas
• Based on application, the other segment is expected to grow at fastest CAGR over the forecast period
• Based on end-use, the hospitals segment held the largest revenue share of the market in 2023. Increasing priority of PRP treatment for aesthetic purposes is a significant factor driving growth of this segment. Clinics segment is expected to grow at fastest CAGR over forecast period owing to rising number of clinics and growing medical tourism
• U.S. dominated the market owing to factors such as supportive regulatory authorities and local presence of many leading manufacturers that focus on developing novel PRP preparation systems

Table of Contents

Chapter 1 Methodology And Scope

• 1.1 Market Segmentation
  • 1.1.1 Regional Scope
  • 1.1.2 Market Definitions
  • 1.1.3 Estimates And Forecast Timeline
• 1.2 Objectives
  • 1.2.1 Objective - 1
  • 1.2.2 Objective - 2
  • 1.2.3 Objective - 3
• 1.3 Research Methodology
• 1.4 Information Procurement
  • 1.4.1 Purchased Database
  • 1.4.2 Gvr's Internal Database
  • 1.4.3 Secondary Sources
  • 1.4.4 Primary Research
  • 1.4.5 Details Of Primary Research
• 1.5 Information Or Data Analysis
  • 1.5.1 Data Analysis Models
• 1.6 Market Formulation & Validation
• 1.7 Model Details
  • 1.7.1 Commodity Flow Analysis
    • 1.7.1.1 Approach 1: Commodity Flow Approach
    • 1.7.1.2 Approach 2: Country Wise Market Estimation Using Bottom-Up Approach
• 1.8 List Of Secondary Sources
• 1.9 List Of Abbreviations

Chapter 2 Executive Summary

• 2.1 Market Snapshot
• 2.2 Type And Application Segment Snapshot
• 2.3 End-Use Segment Snapshot
• 2.4 Competitive Landscape Snapshot

Chapter 3 U.S. And Japan Platelet Rich Plasma Market Variables, Trends, And Scope

• 3.1 U.S. And Japan Platelet Rich Plasma Market Lineage Outlook
  • 3.1.1 Parent Market Outlook
  • 3.1.2 Ancillary Market
• 3.2 Market Dynamics
  • 3.2.1 Market Driver Analysis
    • 3.2.1.1 Rise In Incidence Of Orthopedic Disorders And Sports Injuries
    • 3.2.1.2 Increasing Cosmetic Surgeries
    • 3.2.1.3 Expanding Medical Applications Of Prp
    • 3.2.1.4 Increasing Evidence-Based Studies For Prp-Based Wound Healing
  • 3.2.2 Market Restraint Analysis
    • 3.2.2.1 High Costs Associated With Prp Products
• 3.3 U.S. And Japan Platelet Rich Plasma Market Analysis Tools
  • 3.3.1 Porter's Five Forces Analysis
  • 3.3.2 Pestle Analysis
  • 3.3.3 Key Opinion Perspective Analysis
  • 3.3.4 Market Opportunity Analysis
  • 3.3.5 Buyer Perception Studies
  • 3.3.6 Key Opinion Perspective Analysis

Chapter 4 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Type, 2018 - 2030 (USD Million)

• 4.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Type Movement Analysis
  • 4.1.1 Pure Prp
    • 4.1.1.1 Orthopedics
    • 4.1.1.1.1 Sports Medicine
    • 4.1.1.1.2 Spine
    • 4.1.1.1.3 Trauma
    • 4.1.1.1.4 Foot And Ankle
    • 4.1.1.1.5 Joint Reconstruction
  • 4.1.2 Leukocyte-Rich Rich Prp
    • 4.1.2.1 Orthopedics
    • 4.1.2.1.1 Sports Medicine
    • 4.1.2.1.2 Spine
    • 4.1.2.1.3 Trauma
    • 4.1.2.1.4 Foot And Ankle
    • 4.1.2.1.5 Joint Reconstruction
  • 4.1.3 Others
    • 4.1.3.1 Orthopedics
    • 4.1.3.1.1 Sports Medicine
    • 4.1.3.1.2 Spine
    • 4.1.3.1.3 Trauma
    • 4.1.3.1.4 Foot And Ankle
    • 4.1.3.1.5 Joint Reconstruction

Chapter 5 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By Application, 2018 - 2030 (USD Million)

• 5.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: Application Movement Analysis
  • 5.1.1 Orthopedics
    • 5.1.1.1 Sports Medicine
    • 5.1.1.2 Spine
    • 5.1.1.3 Trauma
    • 5.1.1.4 Foot And Ankle
    • 5.1.1.5 Joint Reconstruction
  • 5.1.2 Others

Chapter 6 U.S. And Japan Platelet Rich Plasma Market - Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 6.1 U.S. And Japan Platelet Rich Plasma (Prp) Market: End-Use Movement Analysis
  • 6.1.1 Hospitals
  • 6.1.2 Clinics
  • 6.1.3 Others

Chapter 7 U.S. And Japan Platelet Rich Plasma (Prp) Market: Country Estimates And Trend Analysis

• 7.1. U.S.
  • 7.1.1 Key Country Dynamics
  • 7.1.2 U.S. Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 7.1.3 Competitive Scenario
  • 7.1.4 Regulatory Framework
  • 7.1.5 Reimbursement Scenario
  • 7.1.6 Japan
    • 7.1.6.1 Key Country Dynamics
    • 7.1.6.2 Japan Platelet Rich Plasma (Prp) Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 7.1.6.3 Competitive Scenario
    • 7.1.6.4 Regulatory Framework
    • 7.1.6.5 Reimbursement Scenario

Chapter 8 Competitive Landscape

• 8.1 Company Categorization
• 8.2 Participants' Overview
• 8.3 Financial Performance
• 8.4 Product Benchmarking
• 8.5 Company Market Share Analysis, 2023
• 8.6 Strategy Mapping
  • 8.6.1 Expansion
  • 8.6.2 Collaborations
  • 8.6.3 New Product Launches
  • 8.6.4 Acquisitions
  • 8.6.5 Others
• 8.7 List Of Emerging Companies
  • 8.7.1 Johnson & Johnson Services, Inc.
  • 8.7.2 Arthrex, Inc.
  • 8.7.3 EmCyte Corporation
  • 8.7.4 Dr. PRP USA LLC
  • 8.7.5 Juventix Regenerative Medical, LLC
  • 8.7.6 Terumo Corporation
  • 8.7.7 Zimmer Biomet
  • 8.7.8 Stryker
  • 8.7.9 Apex Biologix
  • 8.7.10 Celling Biosciences, Inc.
  • 8.7.11 Factor Medical, Inc.
  • 8.7.12 CAREstream America
  • 8.7.13 Royal Biologics.

Chapter 9 Conclusion

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviation
• Table 3 Growth factors involved in stages of wound healing
• Table 4 Growth factors involved in wound healing with their origin
• Table 5 Use of PRP in wound management
• Table 6 Randomized controlled trials: PRP-based wound healing
• Table 7 Some of the prominent manufacturers operating in pure PRP market
• Table 8 Some of the hospitals offering PRP treatment for different applications
• Table 9 Some of the PRP service providers in Japan
• Table 10 Key companies undergoing expansions
• Table 11 Key companies undergoing collaborations
• Table 12 Key companies undergoing new product launches
• Table 13 Key companies undertaking acquisitions
• Table 14 Key companies undertaking other activities
• Table 15 Key companies undertaking other activities
• Table 16 China immunohistochemistry market, by type, 2018 - 2030 (USD Million)
• Table 17 China immunohistochemistry market, by application, 2018 - 2030 (USD Million)
• Table 18 China immunohistochemistry market, by end use, 2018 - 2030 (USD Million)
• Table 19 Japan immunohistochemistry market, by type, 2018 - 2030 (USD Million)
• Table 20 Japan immunohistochemistry market, by application, 2018 - 2030 (USD Million)
• Table 21 Japan immunohistochemistry market, by end use, 2018 - 2030 (USD Million)  

List of Figures

• Fig. 1 U.S. and Japan Platelet rich plasma market segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Value chain based sizing & forecasting
• Fig. 6 QFD modelling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Market snapshot
• Fig. 9 Type and application segment snapshot
• Fig. 10 End-use segment snapshot
• Fig. 11 Competitive landscape snapshot
• Fig. 12 Global platelet rich plasma (PRP) market value, 2023 (USD Million)
• Fig. 13 Market dynamics
• Fig. 14 Prevalence rate of arthritis in the U.S. adults, diagnosed and projected cases
• Fig. 15 Incidence of arthritis in U.S., by age
• Fig. 16 Benefits of PRP treatment in cosmetic facial procedures
• Fig. 17 Common minimal invasive procedures in 2019, U.S.
• Fig. 18 Porter's five forces analysis
• Fig. 19 PESTLE analysis
• Fig. 20 Platelet rich plasma market: End-use outlook and key takeaways
• Fig. 21 U.S. and Japan Platelet rich plasma (PRP) market: Type movement analysis
• Fig. 22 Pure PRP market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 23 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
• Fig. 24 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
• Fig. 25 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
• Fig. 26 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
• Fig. 27 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
• Fig. 28 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
• Fig. 29 Leukocyte-rich PRP market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 30 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
• Fig. 31 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
• Fig. 32 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
• Fig. 33 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
• Fig. 34 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle , 2018 - 2030 (USD Million)
• Fig. 35 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction , 2018 - 2030 (USD Million)
• Fig. 36 Others PRP market estimates and forecast for others, 2018 - 2030 (USD Million)
• Fig. 37 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
• Fig. 38 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
• Fig. 39 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
• Fig. 40 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
• Fig. 41 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
• Fig. 42 U.S. and Japan Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
• Fig. 43 U.S. and Japan Platelet rich plasma (PRP) market: Application outlook and key takeaways
• Fig. 44 U.S. and Japan Platelet rich plasma (PRP) market: Application movement analysis
• Fig. 45 Platelet Rich Plasma (PRP) market estimates and forecast for orthopedics, 2018 - 2030 (USD Million)
• Fig. 46 Platelet Rich Plasma (PRP) market estimates and forecast for sports medicine, 2018 - 2030 (USD Million)
• Fig. 47 Platelet Rich Plasma (PRP) market estimates and forecast for spine, 2018 - 2030 (USD Million)
• Fig. 48 Platelet Rich Plasma (PRP) market estimates and forecast for trauma, 2018 - 2030 (USD Million)
• Fig. 49 Platelet Rich Plasma (PRP) market estimates and forecast for foot and ankle, 2018 - 2030 (USD Million)
• Fig. 50 Platelet Rich Plasma (PRP) market estimates and forecast for joint reconstruction, 2018 - 2030 (USD Million)
• Fig. 51 Platelet Rich Plasma (PRP) market estimates and forecast for others, 2018 - 2030 (USD Million)
• Fig. 52 Percentage of adult population dental clinic visits, U.S.
• Fig. 53 U.S. and Japan Platelet rich Plasma (PRP) market: End-use outlook and key takeaways
• Fig. 54 U.S. and Japan Platelet rich plasma (PRP) market: End-use movement analysis
• Fig. 55 Platelet rich plasma (PRP) market for hospitals, 2018 - 2030 (USD Million)
• Fig. 56 Platelet rich plasma (PRP) market for clinics, 2018 - 2030 (USD Million)
• Fig. 57 Platelet rich plasma (PRP) market for other end uses, 2018 - 2030 (USD Million)
• Fig. 58 Key country dynamics
• Fig. 59 U.S. Platelet Rich Plasma (PRP) market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 Key country dynamics
• Fig. 61 Japan Platelet Rich Plasma (PRP) market estimates and forecast, 2018 - 2030 (USD Million)